1 The mechanisms of vascular tone regulation by extracellular uridine 5'-triphosphate (UTP) were investigated in bovine middle cerebral arterial strips. Changes in cytosolic Ca2+ concentration ([Ca2+],) and force were simultaneously monitored by use of front-surface fluorometry of fura-2. 2 In the arterial strips without endothelium, UTP (0.1 M -1 mM) induced contraction in a concentration-dependent manner. However, when the endothelium was kept intact, cumulative application of UTP (0.1-100 gM) ( 
Introduction
Brain is abundant in UTP (Keppler et al., 1970) . Since UTP has a potent vasoconstrictor action (Urquilla, 1978) , it may be one of the possible spasmogens in cerebral vasospasm after subarachnoid haemorrhage (Shirasawa et al., 1983) . On the other hand, it has been reported that UTP induces prostacyclin (PGI2) production in cultured endothelial cells (Needham et al., 1987; Motte et al., 1993) and endothelium-dependent relaxation of arterial smooth muscle, which is not inhibited by haemoglobin, an inhibitor of endothelium-derived relaxing factor (EDRF) (Hardebo et al., 1987) . Although PGI2 may contribute to the relaxation of vascular smooth muscle (Moncada, 1982) , it remains to be determined whether or not PGI2 production is significantly involved in the UTP-regulation of cerebrovascular tone. UTP elicits [Ca2+] i elevation as potently as ATP in rat aortic smooth muscle cells (Tawada et al., 1987; Erlinge et al., 1993) , implicating the possible involvement of the P2U purinoceptor (one of the subtypes of P2 purinoceptors, which is characterized by the rank order of potency for ATP analogues; UTP = ATP > ATPyS > 2-methylthio -ATP, fl,y -methylene -ATP) (O'Connor et al., 1991) . On the other hand, it was also reported that the vascular smooth muscle has a pyrimidine receptor (von Kiigelgen et al., 1987 (von Kiigelgen et al., , 1990 Juul et al., 1992; Sajag et al., 1992) , which is activated by UTP and distinct from the P2 purinoceptor (Benham, 1989; Ralevic & Burnstock, 1991 Thus, the mechanism underlying the cerebrovascular tone regulation by UTP is not well understood. The purpose of the present study is to investigate, (1) the mechanism of UTPinduced endothelium-dependent relaxation, and (2) the mechanism of UTP-induced contraction of cerebral arterial smooth muscle. To our knowledge, this is the first report showing the P2U receptor-mediated increases in [Ca2+] i and force in vascular smooth muscle.
Methods
Tissue preparation and force measurement Bovine middle cerebral arteries (n =21 vessels) were obtained immediately after slaughter of the animal at a local abattoir 'Author for correspondence at: Division of Molecular Cardiology, and brought to the laboratory in ice-cold physiological saline solution (PSS), as described (Miyagi et al., 1995a, b) . Briefly, segments 1-3 cm from the bifurcation of the internal carotid artery were excised. The arachnoid membranes were carefully excised and strips (1 x 4 mm) cut with scissors were prepared. In the case of endothelium-denuded strips, the luminal surface of the strip was rubbed off gently with a cotton swab under a microscope. The complete denudation of the endothelium was confirmed by a lack of relaxation induced by 1 iM bradykinin. Strips were mounted vertically in a quartz organ bath, being connected to a force-transducer (TB-612T Nihon Koden, Tokyo, Japan). During a 1 h equilibration-period, the strips were stimulated with 118 mM K+-PSS every 15 min, and the resting tension was adjusted to 200 mg.
Chemical denervation
Prior to the experiment, chemical denervation was performed with KH2PO4-and NaHCO3-free PSS containing 20 gM glutathione and 1.2 pM 6-hydroxydopamine, as described by Aprigliano & Hermsmeyer (1976) . In addition, all solutions used in this study contained 3 gM tetrodotoxin, 1 gM phentolamine and 1 gM guanethidine (Agnus et al., 1988) . These procedures for chemical denervation had no effect on the contractile responses to 118 mM K+ -depolarization (Miyagi et al., 1995b) .
[Ca21]i measurement The changes in [Ca21], of bovine middle cerebral arteries were assessed by fura-2 front-surface fluorometry, as described before (Miyagi et al., 1995a, b) . Briefly, vascular strips were loaded with fura-2 by incubating in Dulbecco's modified Eagle's medium containing 50 gM fura-2/AM (an acetoxymethyl ester form) and 5% foetal bovine serum for 4 h at 370C, under aeration with 95% 02 and 5% CO2. The fura-2-loaded strips were washed with normal PSS to remove the dye in the extracellular space, and were then further incubated in normal PSS for 1 h. Fluorescence intensities of the fura-2-Ca21 complex were simultaneously monitored with the force development, using a fluorometer specially designed for fura-2 frontsurface fluorometry (CAM-OF3, Japan, Spectroscopic Co., Tokyo, Japan) (Ushio-Fukai et al., 1993) and the ratio of the fluorescence intensities (500 nm emission) at 340 nm excitation to those at 380 nm excitation was monitored. Before starting each measurement, the responsiveness of each strip to 118 mM K+-PSS was recorded, for the purposes of normalization. The force and fluorescence ratio were expressed as a percentage (% force and % ratio), assuming the values in normal (5.9 mM K+) and 118 mM K+-PSS, to be 0% and 100%, respectively. (Miyagi et al., 1995a, b 
Results
Force development by UTP in cerebral arterial smooth muscle with and without intact endothelium
To determine the characteristics of UTP-induced force development, the arterial strips were stimulated by cumulative application of UTP (0.1 pM-I mM) (Figure 1 ). With intact endothelium, UTP at concentrations below 100 gM did not induce any contraction, but a transient slight decrease of the tone (Figure la,e) . Only at 1 mM, did UTP cause a phasic contraction, the peak level of the force was 38 + 6.6% of the response to 118 mM K+-PSS. In contrast, in the absence of endothelium, UTP induced contraction in a concentrationdependent manner (Figure lb,e) . At a concentration higher than 10 pM, UTP apparently induced contraction; at 1 mM, UTP-induced contraction was 81+13%. The concentrationresponse curves of UTP did not appear to reach maximum at 1 mM, and as a result, therefore the concentrations generating half maximal response (EC50) could not be determined. Thus, the endothelium markedly attenuated the UTP-induced contraction of the arterial strips. To investigate the mechanism underlying the inhibitory effect of endothelium on UTP-induced contraction, strips were incubated with 100 gM Nw-nitro-L-arginine (L-NOARG), which is known to inhibit nitric oxide synthesis (Moncada et al., 1991) , for 40 min before the initiation of the experiment. In the strips preincubated with 100 pM L-NOARG, UTP-induced contraction was first observed at 100 gM and reached 80 + 1.7% of the level of 118 mM K+-induced contraction at 1 mM, the extent of which was similar to that of endothelium-denuded strips (79 + 10%) (Figure lc,e). Preincubation with 10 gM indomethacin for 40 min had no effect on this inhibitory effect of endothelium at all concentrations of UTP examined (P>0.05) (Figure ld,e).
U-46619 (a stable analogue of thromboxane A2 induced a sustained contraction (in the presence of endothelium, 112+4.1%; in the absence of endothelium, 112+4.8%) (Figure Figure   3d ). At the end of each experiment, U-46619 (1 giM) and bradykinin (1Mm) were added to confirm that there was no nonspecific toxic condition in this protocol to affect the contractility of smooth muscle and that endothelial cells were successfully removed, respectively.
Mechanism underlying UTP-induced contraction of cerebral arterial smooth muscle (Figure 5a ) and the same procedures were car-UTP 1 mM 
Discussion
In this study, we clarified for the first time that: (1) UTP induces a relaxation of cerebral artery mainly through endothelium-derived relaxing factor (EDRF); (2) and the influx of extracellular Ca2+) and contraction, without affecting the Ca2+-sensitivity of the contractile apparatus of smooth muscle. Although bovine cerebral artery has a vasoconstricting P2U receptor, it seems not important in the regulation of vascular tone where the vasoconstriction is attenuated by EDRF simultaneously released from adjacent endothelial cells. It was reported that UTP also induces PGI2 release from smooth muscle cells (Demolle et al., 1988) and endothelial cells (Needham et al., 1987) and haemoglobin-insensitive endothelium-dependent relaxation of pial artery, which is compatible with the involvement of PGI2 (Hardebo et al., 1987) . However, in our preparation, the endothelium-denuded strips failed to relax in response to UTP (Figure 2b ), and the inhibition of PGI2 formation with indomethacin in endothelial cells on arterial strips did not attenuate the endothelium-dependent relaxation induced by UTP (Figure 2d ). These findings suggest that possible production of PGI2 in smooth muscle or endothelium, if any, may not have a major role in the regulation of cerebrovascular tone by UTP. In perfused rat mesenteric arterial bed, Nw-nitro-L-arginine methyl ester partially inhibited the UTP-induced endothelium-dependent decrease of perfusion pressure (Ralevic & Burnstock, 1991) , suggesting the possible involvement of other mediators (PGI2 or endothelium-derived hyperpolarizing factor) in the UTPinduced vasorelaxation. In our study, L-NOARG, an inhibitor of conversion pathway of L-arginine to nitric oxide, completely abolished the vasorelaxant effect of UTP both on resting tone (Figure 1 ) and on U-46619-raised tone (Figure 2 ) of vascular strips with intact endothelium. Therefore, it is concluded that EDRF is a major mediator in UTP-induced endothelium-dependent relaxation of bovine cerebral artery.
Another nucleotide, ATP also induces phasic contraction of vascular smooth muscle. Given the absence of selective antagonists, the subclassification of the ATP receptors (P2 purinoceptors) was based on the rank order of agonist potency for structural analogues of ATP (Burnstock & Kennedy, 1985; O'Connor & Leff, 1990; O'Connor et al., 1991) . According to this classification, the purinoceptors regulating vascular tone are P2X (a,fl-methylene ATP >ATP > 2-methylthio-ATP) in smooth muscle and P2y (2-methylthio-ATP > ATP> cx,-methylene ATP) in endothelial cells. The activation of the P2x purinoceptor induces Ca2" influx through the ligand-gated Ca2" channel (Benham, 1989) , without the release of intracellular Ca2". In our study, UTP a pyrimidine nucleotide, induced a transient increase in [Ca2+] i and force in the Ca2+-free condition also; therefore it is unlikely that UTP-induced
[Ca2+]i mobilization may be mediated by P2X purinoceptor, as being compatible with the desensitization study by von Kugelgen et al. (1990) . Furthermore, UTP and ATP induced additive contractions in P2x-desensitized strips (Figure 3a,b  and d ). In addition, in the P2x-desensitized state, ATP and UTP showed cross-desensitization each other (Figure 3a and b), indicating the presence of the common receptor for ATP and UTP. Since it is clear that UTP activates one of the P2 purinoceptors (UTP = ATP > ATPyS > ADP > 2MeSATP) associated with various biological responses (O'Connor et al., 1991) , this subtype has been named 'P2U' or 'nucleotide receptor'. The desensitization to ATPyS, another agonist of the P2U receptor, also markedly inhibited UTP-induced contraction (Figure 3c ), supporting the involvement of the P2u receptor in UTP-induced contraction. Although ATP induced an additive contraction in P2x-desensitized strips, the additive contraction was smaller than that induced by UTP (Figure 3b ). Because ATP is a nonselective agonist of P2 receptors and is a precursor of P1 receptor agonists, it is likely that ATP may stimulate the other subtypes, distinct from P2x and P2u receptors, or may change to AMP or adenosine that activates P1 receptors, respectively. Therefore, the possible involvement of P2Y or other P2 receptors and P1 receptors activation cannot be excluded in the attenuation of ATP-stimulated P2u-contraction observed in this study (Figure 3b ). Vascular endothelial cells have P2U purinoceptors, which mediate both ATP-and UTPinduced phosphatidylinositol hydrolysis and release of intracellular Ca2+ in endothelial cells (Motte et al., 1993) . Although the existence of the P2U purinoceptor has been suggested to induce [Ca2+]i elevation and proliferation in smooth muscle cells (Tawada et al., 1987; Erlinge et al., 1993) , the vasoconstriction mediated by the P2U receptor has never been reported. Our findings that ATP and UTP induced cross desensitization to each other, indicates the first evidence of a vasoconstriction-mediating P2U receptor.
In bovine middle cerebral arterial strips, the time-course of UTP-induced contraction included phasic and sustained components, which was very similar to the time course of human basilar artery (White & Robertson, 1987) . Juul et al. (1992) observed a large sustained contraction induced by UTP in rat mesenteric artery and there was no cross-desensitization between UTP and ATP. In the present study, since the observed UTP-induced contractions are quite different in potency and time-course from those of Juul et al. (1992) (Abe et al., 1990) and U-46619 (Miyagi et al., 1995a) . In addition to increase in [Ca2+], it is well established that the force of smooth muscle is also regulated by the Ca2+-sensitivity of the contractile apparatus (Somlyo & Somlyo, 1994) , the mechanism of which may involve some regulators: activation of protein kinase C (Nishimura et at., 1988) , and inhibition of myosin light chain phosphatase (Kitazawa & Somlyo, 1991) not observed in the case of the UTP-induced contraction ( Figure 5d ). It is suggested that distinct G-proteins may be involved in Ca2" release and Ca2" sensitization (Kobayashi et al., 1991) and the efficacy of a given agonist can differ greatly in activating IP3 formation and diacylglycerol formation, which activates Ca2+ release and Ca2+ sensitization, respectively (Somlyo & Somlyo, 1994) . Therefore, the absence of influx, and the other is the rapid hydrolysis of extracellular UTP. However, the latter (rapid hydrolysis of UTP in 10 min) is unlikely because the UTP concentration used was sufficiently high (1 mM) in a 6 ml organ bath. In addition, pretreatment with cx,f-methylene-ADP, which was reported to inhibit ectonucleotidase (Williams & Braunwalder, 1986) and hydrolysis for UTP to UDP (Richards et al., 1993) , did not affect the action of UTP on the [Ca2+]i-force relationship. These findings suggest that the hydrolysis of extracellular UTP, if it occurs, does not have a major role in the relatively phasic contraction by UTP (Figure 4) . Recently, evidence has been increasing of the physiological importance of nitric oxide (EDRF or neurotransmitter) in the regulation of regional cerebral blood flow (Kovach et al., 1992) . Nitric oxide diffuses into smooth muscle cells and stimulates the accumulation of cyclic GMP (Rapoport & Murad, 1983) and the activation of cyclic GMP-dependent protein kinase (Ignarro & Kadowitz, 1987) . Nitric oxide-induced activation of cyclic GMP-dependent protein kinase decreases
[Ca2 ] and Ca2+-sensitivity of the contractile apparatus of vascular smooth muscle, leading to vasorelaxation (Abe et al., 1990) . Haemoglobin, an inhibitor of nitric oxide, inhibits endothelium-dependent relaxation of vascular smooth muscle (Martin et al., 1985) . In the pathological condition such as subarachnoid haemorrhage, where cerebral arteries are exposed to many direct or indirect vasoactive substances including haemoglobin, the dysfunction of endotheliumdependent vasodilatation can be the significant cause of cerebral vasospasm (Fujiwara et al., 1986) . UTP, as observed in the present study, is one of the vasoactive substances that have dual effects on vascular tone, although UTP generates contraction only at high concentrations in the strips with intact endothelium. Therefore, a physiological role of extracellular UTP may be to act as a vasodilator in the regulation of local vascular tone, mainly by an endothelium-dependent mechanism rather than by a direct constrictor mechanism in smooth muscle. However, once the endothelial function is degenerated or is damaged (e.g. arteriosclerosis, subarachnoid haemorrhage), the vasoconstrictor action of UTP may appear, causing cerebral vasospasm. Hardebo et al. (1987) also suggested that the site of UTP release in situ (luminal or abluminal side of vascular wall) may decide the direction of vasomotor action of UTP.
The present observations clarified the underlying mechanisms of vascular tone regulation by UTP in bovine middle cerebral artery. Namely, UTP induces endothelium-dependent relaxation mediated exclusively by EDRF. At high concentrations, UTP induces contraction of cerebral arterial smooth muscle through the P2u receptor, the activation of which leads to the modest release of intracellular Ca2+ and the influx of extracellular Ca2 , without affecting the Ca2+-sensitivity of the contractile apparatus in smooth muscle. However, UTP elicits a relaxant action rather than a contractile action under physiological (endothelium-intact) conditions in the cerebral artery.
